DOI: 10.1186/s40168-023-01696-7Tick-borne diseases, such as boreliosis (Lyme disease) or anaplasmosis, are on the rise...
Highlights Articles
Vaiomer will be attending «Journées Polepharma de Microbiomique, 4ème édition»
Vaiomer is happy to announce that we will take part in the 4th edition of « Journées Polepharma De Microbiomique » on...
Vaiomer is taking part to « 7èmes JOURNEES SCIENTIFIQUES FRANCOPHONES du CALM»
Vaiomer is happy to announce its participation to "7èmes JOURNEES SCIENTIFIQUES FRANCOPHONES du Club Alzheimer de...
Vaiomer is participating in the Genotoul Scientific Day-HOLOBIONTES
Vaiomer is happy to announce that we will be participating in the “Genotoul Scientific Day: HOLOBIONTES Understanding...
Probiotic strains translocate to the tumor and improve ICI efficacy through indole-3-aldehyde release
DOI: 10.1016/j.cell.2023.03.011In recent years, several studies have shown the importance of both the gut and the...
The human tumor microenvironment is colonized by cancer type–specific bacteria and fungi
DOI N°1: 10.1126/science.aay9189DOI N° 2: 10.1016/j.cell.2022.09.005Several studies have shown the importance of the...
Microbiomes modulate the local immune response, influencing immunotherapy response and toxicity
doi: 10.21037/atm-20-6427Immunotherapy has revolutionized the treatment of several cancers. However, it remains...
Meet Vaiomer at the AFSSI Connexions 2023 – Montpellier
Vaiomer is participating in «la 10e édition des AFSSI Connexions» on July 04 and 05 in MontpellierVaiomer’s...
Resistance to anti-PD-1 immunotherapy can be attributed to the gut microbiome
DOI: 10.1126/science.aan4236 DOI: 10.1126/science.aao3290 DOI: 10.1126/science.aan370Immunotherapies (Immune...